An excerpt of guidance for design and endpoints of clinical trials in chronic hepatitis B-Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference

An excerpt of guidance for design and endpoints of clinical trials in chronic hepatitis B-Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference

Bibliographic Details
Main Author:	DENG Rui
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Hepatology 2020-03-01
Series:	Linchuang Gandanbing Zazhi
Online Access:	http://www.lcgdbzz.org/qk_content.asp?id=10711

Similar Items

An excerpt of update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
by: ZHANG Jingqiao, et al.
Published: (2018-04-01)

An excerpt of New 2015 AASLD guidelines for treatment of chronic hepatitis B
by: XU Ying, et al.
Published: (2016-02-01)

Interpretation of the practice guidelines for alcoholic liver disease by EASL in 2012 and AASLD in 2010
by: CHANG Binxia
Published: (2015-01-01)

An excerpt of EASL clinical practice guideline: Occupational liver diseases (2019)
by: LI Fan
Published: (2020-02-01)

An excerpt of AASLD guidelines for the treatment of hepatocellular carcinoma (2016)
by: LI Jing, et al.
Published: (2017-04-01)

An excerpt of AASLD guidelines for the treatment of hepatocellular carcinoma（2018）
by: ZHANG Hong, et al.
Published: (2018-04-01)

Informative noncompliance in endpoint trials
by: Iglewicz Boris, et al.
Published: (2004-07-01)

An excerpt of 2015 EASL clinical practical guidelines: vascular diseases of the liver
by: GAO Fan, et al.
Published: (2016-01-01)

The analysis of multiple endpoints in clinical trials
by: James, Susan Elizabeth
Published: (1993)

To and the construction of endpoints
by: Lise Hamelin
Published: (2012-12-01)

Clinical Trial Risk in Hepatitis C: Endpoint Selection and Drug Action
by: Nicole A. Tillie, et al.
Published: (2016-01-01)

Secure SIP between IPv4 endpoints and IPv6 endpoints
by: Jiang, Xing
Published: (2003)

Understanding the Use of Composite Endpoints in Clinical Trials
by: C. Eric McCoy
Published: (2018-06-01)

Trial design and analysis of endpoints in HIV vaccine trials
by: Richert, Laura
Published: (2013)

Surrogate Endpoints in Medicine
by: Sudhir Srivastava, et al.
Published: (2002-01-01)

Molecular pharmacodynamic endpoints /
by: Weaver, Jean M.
Published: (1997)

Recent update of the 2017 Korean Association for the Study of the Liver (KASL) treatment guidelines of chronic hepatitis C: Comparison of guidelines from other continents, 2017 AASLD/IDSA and 2016 EASL
by: Jong Eun Yeon
Published: (2018-09-01)

Analys av säkerhetslösningarna Cisco Secure Endpoint och Microsoft Defender for Endpoint
by: Möllberg, Casper, et al.
Published: (2021)

Methodology of establishing predictive models for clinical endpoints in patients with chronic hepatitis B
by: WU Shanshan
Published: (2020-09-01)

An excerpt of EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis(2017)
by: SUN Chunyan, et al.
Published: (2017-10-01)

An excerpt of AASLD expert panel consensus statement: Vaccines to prevent COVID-19 infection in patients with liver disease
by: ZHAO Lianhui
Published: (2021-05-01)

Improving the analysis of composite endpoints in rare disease trials
by: Martina McMenamin, et al.
Published: (2018-05-01)

Significance of biomarkers and surrogate endpoints in preclinical and clinical trials
by: Ilić Katarina, et al.
Published: (2007-01-01)

Evaluation of the True Endpoint of Clinical Trials for Cancer Cachexia
by: Tateaki Naito
Published: (2019-01-01)

Patients’ preferences for selection of endpoints in cardiovascular clinical trials
by: Robert D. Chow, et al.
Published: (2014-02-01)

Alternative Endpoints and Analysis Techniques in Kidney Transplant Trials
by: Fergusson, Nicholas Anthony
Published: (2017)

Evaluating multiple endpoints in heart failure clinical trials
by: Yang, Yijun
Published: (2016)

Interpretation of composite endpoints in Urology
by: C.F.S. Jensen, et al.
Published: (2020-07-01)

Compton scattering in the Endpoint Model
by: Sumeet Dagaonkar
Published: (2018-11-01)

Shared Contract-Obedient Endpoints
by: Étienne Lozes, et al.
Published: (2012-12-01)

The problems of Endpoint DLP systems
by: N. S. Morozova
Published: (2011-12-01)

Calcium affects on vascular endpoints
by: Patel Vaishali B, et al.
Published: (2012-03-01)

Endpoints for Lymphatic Filariasis Programs
by: Caroline A. Grady, et al.
Published: (2007-04-01)

Modified Operators Interpolating at Endpoints
by: Ana Maria Acu, et al.
Published: (2021-08-01)

Statistical Analysis in Surrogate Endpoints
by: SU, TE-CHIH, et al.
Published: (1998)

Fingerprinting Encrypted Tunnel Endpoints
by: Izadinia, Vafa Dario
Published: (2013)

Restructuring endpoint congestion control
by: Narayan, Akshay, et al.
Published: (2021)

Imputation of a true endpoint from a surrogate: application to a cluster randomized controlled trial with partial information on the true endpoint
by: Duffy Stephen W, et al.
Published: (2003-09-01)

Roles of Hepatitis B Seromarkers in Predicting Treatment Endpoints and Clinical Outcomes in Chronic Hepatitis B
by: Jessica Liu, et al.
Published: (2012)

Recommendation about hepatitis C guidance: AASLD-IDSA recommendations for testing managing, and treating adults infected with hepatitis C virus
by: JIANG Yong, et al.
Published: (2015-09-01)